Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-cysteine is the D-enantiomer of cysteine, a non-essential thiol-containing amino acid with the molecular formula C₃H₇NO₂S. Unlike the more common L-cysteine found in proteins, D-cysteine is not incorporated into mammalian proteins but can be found in some bacterial cell walls and as a metabolic intermediate. It has been studied for its antibacterial properties and as a regulator of neural progenitor cell proliferation. Experimental research also explores its potential to reverse opioid-induced respiratory depression when used as an ester derivative, though the parent compound itself appears inactive in this context[1][3][5]. Its mechanism of action may involve redox-dependent processes due to its thiol group.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-cysteine.